ADIPOQ and interstitial lung disease: Monitoring serum adiponectin levels during intravenous pulse cyclophosphamide (IVCY) treatment might assist in identifying systemic sclerosis patients with treatment-resistant interstitial lung disease and those at an increased risk for exacerbation during follow-up [33].